Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
10%
Ph not_applicable
1
10%
Ph phase_4
5
50%
Ph phase_3
2
20%

Phase Distribution

0

Early Stage

1

Mid Stage

7

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
5(55.6%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(6)
Terminated(1)
Other(2)

Detailed Status

Completed6
unknown2
Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (11.1%)
Phase 32 (22.2%)
Phase 45 (55.6%)
N/A1 (11.1%)

Trials by Status

completed660%
not_yet_recruiting110%
unknown220%
withdrawn110%

Recent Activity

0 active trials
Showing 5 of 10
not_yet_recruitingphase_2

Efficacy and Safety of Parecoxib vs. Indomethacin in Preventing Post-ERCP Pancreatitis

NCT06623513
completedphase_3

Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure

NCT03059238
completed

Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial Chemoembolization

NCT02552745
completedphase_4

Effect of Parecoxib Sodium and Flurbiprofen Injection on Postoperative Shivering

NCT02569905
completedphase_4

Parecoxib for Pain Management After Total Knee Arthroplasty and Total Hip Arthroplasty

NCT02272660
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT06623513Phase 2

Efficacy and Safety of Parecoxib vs. Indomethacin in Preventing Post-ERCP Pancreatitis

Not Yet Recruiting
NCT03059238Phase 3

Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure

Completed
NCT02552745

Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial Chemoembolization

Completed
NCT02569905Phase 4

Effect of Parecoxib Sodium and Flurbiprofen Injection on Postoperative Shivering

Completed
NCT02272660Phase 4

Parecoxib for Pain Management After Total Knee Arthroplasty and Total Hip Arthroplasty

Completed
NCT01186159Phase 4

The Correlation of COX-2 Expression in Human Polymorphonuclear Leukocytes/Macrophages (PMNL/MP) and Postoperative Pain

Completed
NCT02204878Phase 4

Role of Parecoxib Sodium for Postoperative Pain Management in Open Hepatectomy

Unknown
NCT01566669Not Applicable

Efficacy and Safety of Parecoxib on Morphine Patient-controlled Epidural Analgesia (PCEA) After Gynecologic Surgery

Completed
NCT00435747Phase 4

Efficacy And Safety Of Parecoxib IV/IM 40 Mg Vs Placebo Following Sub Muscular Breast Augmentation

Withdrawn
NCT01311804Phase 3

An Efficacy and Safety Study of Periarticular Parecoxib Sodium for Pain Management in Total Knee Arthroplasty

Unknown

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10